Citigroup’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-49
| Closed | – | – | 5031 |
|
|
2022
Q3 | $0 | Sell |
49
-15
| -23% | – | ﹤0.01% | 5343 |
|
|
2022
Q2 | $1K | Sell |
64
-638
| -91% | -$9.97K | ﹤0.01% | 5271 |
|
|
2022
Q1 | $26K | Buy |
702
+573
| +444% | +$21.2K | ﹤0.01% | 4299 |
|
|
2021
Q4 | $10K | Buy |
+129
| New | +$10K | ﹤0.01% | 4785 |
|